Suven Life Sciences Limited
NSE: SUVEN | Information Technology
Market Fundamentals
Stock Intelligence & News
West Bengal Cabinet Clears Panel To Examine Draft Uniform Civil Code Bill
The Cabinet's decision comes days after CM Suvendu Adhikari formally initiated the process of implementing the UCC in West Bengal.
Read Full Analysis →Market Trading Guide: Suven Life Sciences among 2 stock recommendations for Friday
Indian markets advanced on easing crude prices and dovish Fed commentary, boosting risk appetite. Analysts recommend buying NDR Auto and Suven Life Sciences after bullish breakouts, while investors await US jobs data, the India–Japan summit and Q1FY27 earnings.
Read Full Analysis →Suven Life Sciences Limited
SUVEN LIFE SCIENCES LIMITED has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Suven Life Sciences Limited
Suven Life Sciences Limited has informed the Exchange regarding allotment of 271970 securities pursuant to ESOP/ESPS at its NRC meeting held on Jun 22, 2026 |SUBJECT: Allotment of Securities
Read Full Analysis →Calcutta Stock Exchange May Get Revived As BJP-Led Bengal Govt Eyes Private Investments
West Bengal Chief Minister Suvendu Adhikari and Finance Minister Swapan Dasgupta during a press conference after the presentation of the first Budget of the BJP government in the Legislative Assembly in Kolkata on Monday.
Read Full Analysis →West Bengal Launches Yuva Shakti Scheme For Jobless Youth; Assistance Up To Rs 3,000 A Month
West Bengal Chief Minister Suvendu Adhikari and Finance Minister Swapan Dasgupta display copies of the state Budget after its presentation in the Legislative Assembly in Kolkata on Monday.
Read Full Analysis →Suven Life Sciences Limited
Suven Life Sciences Limited has informed the Exchange regarding a press release dated Jun 22, 2026, titled "Suven Life Sciences to showcase its Differentiated CNS Clinical Candidates and Partnering Strategies at BIO International Convention 2026, 22-25, June 2026, San Diego, USA.". |SUBJECT: Press Release
Read Full Analysis →Suven Life Sciences Limited
Suven Life Sciences Limited has informed the Exchange regarding a press release dated Jun 17, 2026, titled "Suven Life Sciences announces Positive Topline results from Phase-2b clinical Proof-of-Concept trial of Ropanicant for the treatment of Major Depressive Disorder". |SUBJECT: Press Release
Read Full Analysis →Suven Life Sciences Limited
Venkateswarlu Jasti has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Suven Life Sciences Limited
Suven Life Sciences Limited has informed the Exchange regarding a press release dated Jun 16, 2026, titled "Suven Life Sciences announces successful completion and topline results of First-in-Human (FIH) Phase-1 clinical study of SUVN-I6107, a Muscarinic M1 Positive Allosteric Modulator (M1-PAM) and its advancement into Phase-2 clinical development". |SUBJECT: Press Release
Read Full Analysis →Get instant alerts when SUVEN breaks news
Join investors who track Suven Life Sciences Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for SUVEN?
SUVEN is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Suven Life Sciences Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding SUVEN to your custom watchlist.